5 Publikationen
-
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2985604L. Schürmann, M. Bredehorst, A. I. González González, C. Muth, V. van der Wardt, S. Puzhko, and J. Haasenritter, “Recommendations for the primary prevention of atherosclerotic cardiovascular disease in primary care: study protocol for a systematic guideline review”, BMJ Open, 2023, 13, : e074788.PUB | DOI | WoS | PubMed | Europe PMC
-
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2986016N. Sourial, O. Beauchet, K. Kruglova, S. Robins, E. Margo-Dermer, A. Quesnel-Vallée, C. Launay, L. Dassieu, C. Godard-Sebillotte, S. Karunananthan, et al., “Profiles of socially isolated community-dwelling older adults during the COVID-19 pandemic: A latent class analysis”, Maturitas, 2023, 171, 1-6.PUB | DOI
-
2022 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2986019L. Dassieu, E. Develay, O. Beauchet, A. Quesnel-Vallée, C. Godard-Sebillotte, E. Tchouaket, S. Puzhko, S. Karunananthan, P. Archambault, C. Launay, et al., “Implementing a Telehealth Support Tool for Community-Dwelling Older Adults During the COVID-19 Pandemic: A Qualitative Investigation of Provider Experiences”, Journal of Aging & Social Policy, 2022, 1-18.PUB | DOI
-
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2966735S. Puzhko, T. Schuster, C. Renoux, T. A. Barnett, K. Munro, and G. Bartlett-Esquilant, “The role of the excess weight status in the risk of hospitalizations for patients with depression prescribed obesogenic antidepressants”, Pharmacoepidemiology and Drug Safety , 2022, 31, 424-425.PUB | WoS
-
2021 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2965160S. Puzhko, T. Schuster, T. A. Barnett, C. Renoux, K. Munro, D. Barber, and G. Bartlett, “Difference in patterns of prescribing antidepressants known for their weight-modulating and cardiovascular side effects for patients with obesity compared to patients with normal weight”, Journal of Affective Disorders, 2021, 295, 1310-1318.PUB | DOI | WoS | PubMed | Europe PMC